AI Platform

BraineHealth’s AI Platform is the foundation of our US Patent 11,908,579 B2, driving scalable AI solutions for global healthcare.

With 99% accuracy in simulations—rooted in a 2018 KTH thesis—this platform powers inversion technology that outperforms Microsoft’s MAI-DxO. Handling 20,000+ cases and 200,000 observables, it extends to finance and engineering.

Featured in USA News, BizWeekly and AP across 450+ outlets, it targets the $500B AI market by 2032. Explore licensing today.

License the Patent | Contact Us